top of page

ScreeNingBio's Cell Solution:
Skip Months Of Resistance Development Steps

​​Multiple Mechanisms of Resistance

  • Receptor Desensitization / Downregulation

  • Signaling Pathway Adaptation

  • Drug Efflux / Transporter Overexpression

  • Mutation of Drug Targets

  • Tumor Microenvironmental Resistance

Shorten turn around time

  • Ready-to-use cell line for your drug resistance study

Modeling Resistance in vitro/vivo

  • Ideal tool to study drug resistance in vitro and in vivo

​

Weixin Screenshot_20251229173804.png
Target Receptors
按 类别-Target Receptors 篩選
Species
按 类别-Species 篩選
Assay Mode
按 类别-Assay Mode 篩選
Parental Line
按 类别-Receptor Form 篩選
SW620 Bortezomib Drug Resistance Cell

Drug: Bortezomib

PARENTAL LINE: SW620

DEVELOPMENT METHOD: Contiuous Expose

CATALOG: SNB-DR-0004



SW620 Fludarabine Drug Resistance Cell

Drug: Fludarabine

PARENTAL LINE: SW620

DEVELOPMENT METHOD: Contiuous Expose

CATALOG: SNB-DR-0005



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page